OPKO HEALTH, INC. (OPK)
About OPKO HEALTH, INC.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $606.9M
- Net income
- -$225.7M
- Total assets
- $1.9B
- Market cap
- $1.1B
- Gross margin
- 33.9%
- Operating margin
- -19.3%
- Net margin
- -37.2%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $606.9M
- Cost of revenue
- $400.9M
- Gross profit
- $205.9M
- Operating expenses
- $323.3M
- Operating income
- -$117.4M
- Income tax
- -$15.7M
- Net income
- -$225.7M
- EPS (basic)
- $-0.30
- EPS (diluted)
- $-0.30
Balance sheet
- Total assets
- $1.9B
- Current assets
- $581.9M
- Total liabilities
- $664.0M
- Current liabilities
- $146.7M
- Shareholders’ equity
- $1.3B
Cash flow
- Operating cash flow
- -$178.5M
- Investing cash flow
- $230.3M
- Financing cash flow
- -$118.1M
- Net cash flow
- -$66.3M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $1.1B
- EPS (diluted)
- $-0.3
- Shares outstanding
- 891.3M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Nov 2, 1995
Opko Health, Inc. (OPK) Stock Price
- Reported a net loss of $225.7M in FY2025.
- Revenue declined 58% from FY2020 to FY2025.
- Gross margin of 33.9%, net margin -37.2%.
- Trading 23% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review OPKO HEALTH, INC..
Write a review
News about OPKO HEALTH, INC.
News & sentiment via Polygon.io
Opko Health, Inc.: frequently asked questions
Is Opko Health, Inc. an American company?
Opko Health, Inc. is a US-based company headquartered in Miami, Florida, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Opko Health, Inc. headquartered?
Opko Health, Inc. is headquartered in Miami, Florida, United States.
Is Opko Health, Inc. publicly traded?
Yes — Opko Health, Inc. is a publicly traded company. Its stock trades under the ticker symbol OPK on the NASDAQ.
What does Opko Health, Inc. do?
Opko Health, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
